Affimed Therapeutics' IPO

Affimed Therapeutics raised a round of funding on September 12, 2014. Investors include Public.

Affimed Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies. Affimed's product candidates are being developed in the…

Articles about Affimed Therapeutics' IPO: